Shareholder Return: 3-year average, Sales Growth: 3-year Compounded Annual Growth Rate, Return On Equity: 3-year Return on Equity. The company, which focuses on the formulations business, has ...

As a part of this deal, APL also acquired high profile OTC ... with China National Pharmaceutical Group Corporation (Sinopharm) to divest in its subsidiary company Aurobindo (Datong) Bio Pharma ...

Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. | ...

In May this year, the pharma major's unit situated at Jedcherla, Hyderabad received Form 483 with six observations from USFDA after an inspection. (File/Representational image) Revenues at Rs 58.1 ...

Eugia Pharma, a subsidiary of Aurobindo Pharma, has secured final USFDA approval for manufacturing and marketing Dasatinib ...

Aurobindo Pharma, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1200.55. The stock has experienced fluctuations today ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Aurobindo ...

As per the company, the drug functions by blocking a protein called RANKL, which is responsible for breaking down bone tissue.

The impact, it said, would be higher for companies such as Aurobindo, Dr Reddy’s, Lupin, Sun Pharma, and Zydus Life. A 50 per cent tariff to be borne by Indian pharma may lead to 2-22 per cent ...

February 19, 2025 Indian pharma stocks drop on Trump's tariff plans An index of Indian pharmaceutical company shares slid ... February 6, 2025 India's Aurobindo Pharma posts third-quarter profit ...